Метаболические факторы в патогенезе мигрени и головокружения
https://doi.org/10.33667/2078-5631-2020-33-18-20
Аннотация
Об авторе
А. С. БеденкоРоссия
аспирант кафедры неврологии и нейрохирургии
Москва
Список литературы
1. Алексеев В. В. Диагностика и лечение мигрени. Российский медицинский журнал (РМЖ), 2002; 6 (28): 1228.
2. Табеева Г. Р. Головная боль: руководство для врачей 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2018. 296 с.
3. Осипова В. В. Мигрень: клиника, диагностика и подходы к лечению. ФАРМАТЕКА. 2008; 20: 43–47.
4. Гассиева Д. М., Замерград М. В., Табеева Г. Р. Взаимосвязь мигрени и вестибулярных расстройств. Эпилепсия и пароксизмальные состояния. 2019; 11 (1): 88–96. DOI: 10.17749/20778333.2019.11.1.88–96.
5. Lempert T. et al. Vestibular migraine: Diagnostic criteria. Journal of Vestibular Research 2012; 22: 167–172. DOI: 10.3233/VES-2012–0453.
6. Gazquez I., Lopez-Escamez J. A. Genetics of recurrent vertigo and vestibular disorders. Curr Genomics. 2011; 12: 443–450. DOI: 10.2174/138920211797248600.
7. Neuhauser H. K., Radtke A. von Brevern M. et al. Migrainous vertigo: Prevalence and impact on quality of life. Neurology. 2006; 67: 1028–1033. DOI: 10.1212/01.wnl.0000237539.09942.06.
8. Weiller C., May A., Limmroth V. et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995; 1: 658–660. DOI: 10.1038/nm0795–658.
9. Chu C. H., Liu C. J., Lin L. Y., Chen T. J., Wang S. J. Migraine is associated with a increased risk for benign paroxysmal positional vertigo: a nationwide population-based study. J Headache Pain. 2015; 16: 62. DOI: 10.1186/s10194–015–0547-z.
10. Gopen Q., Viirre E., Anderson J: Epidemiologic study to explore links between Meniere syndrome and migraine headache. Ear, Nose and Throat Journal. 2009; 88 (11): 1200–1204. DOI: 10.1111/j.1526–4610.2009.01557.x.
11. Vanmolkot F. H., de Hoon J. N. Increased C-reactive protein in young adult patients with migraine. Cephalalgia. 2007; 27 (7): 843–846.
12. Welch K. M., Brandes A. W., Salerno L., Brandes J. L.C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006; 46 (2): 197–19.
13. Turan H., Horasanli B., Ugur M., Arslan H. (2011) Procalcitonin levels in migraine patients. Can J Neurol Sci. 2011; 38 (1): 124–128.
14. Tae-Jin Song, Min-Kyung Chu, Jong-Hee Sohn, Hong-Yup Ahn, Sun Hwa Lee, Soo-Jin Cho. Effect of Vitamin D Deficiency on the Frequency of Headaches in Migraine. J Clin Neurol. 2018; 14 (3): 366–373. DOI: 10.3988/jcn.2018.14.3.366.
15. Urvish Patel, Nishanth Kodumuri, Preeti Malik, Amita Kapoor, Princy Malhi, Kulin Patel, Saleha Saiyed, Liseth Lavado and Vinod Kapoor. Hypocalcemia and Vitamin D Deficiency amongst Migraine Patients: A Nationwide Retrospective Study. Medicina. 2019; 55: 407. DOI: 10.3390/medicina55080407.
16. Lippi G., Cervellin G., Mattiuzzi C. No Evidence for an Association of Vitamin D Deficiency and Migraine: A Systematic Review of the Literature. BioMed research international. 2014. DOI: 10.1155/2014/827635.
17. Togha M, Razeghi Jahromi S, Ghorbani Z, Martami F, Seifishahpar M. Serum Vitamin D Status in a Group of Migraine Patients Compared With Healthy Controls: A Case-Control Study. Headache. 2018; 58 (10): 1530–40.
18. Rapisarda L., Mazza M. R., Tosto F., Gambardella A., Bono F., Sarica A. Relationship between severity of migraine and vitamin D deficiency: a case-control study. Neurol Sci. 2018; 39 (1):167–168.
19. Zandifar A., Masjedi S. S., Banihashemi M., Asgari F., Manouchehri N., EbrahimiHet al Vitamin Dstatus in migraine patients: a case-control study. Biomed Res Int. 2014: 514782.
20. Celikbilek A., Gocmen A. Y., Zararsiz G., Tanik N., Ak H., Borekci E., Delibas N. Serum levels of vitamin D, vitamin D-binding protein and vitamin D receptor in migraine patients from central Anatolia region. Int J Clin Pract. 2014; 68 (10): 1272–1277.
21. Knutsen K. V., Madar A. A., Brekke M., Meyer H. E., Natvig B., Mdala I., Lagerlv P. Effect of vitamin D on musculoskeletal pain and headache: a randomized, double-blind, placebo-controlled trial among adult ethnic minorities in Norway. Pain. 2014; 155 (12): 2591–2598.
22. Mottaghi T., Askari G., Khorvash F., Maracy M. R. Effect of vitamin D supplementation on symptoms and C-reactive protein in migraine patients. J Res Med Sci. 2015; 20 (5): 477–482.
23. Gazerani P., Fuglsang R., Pedersen J. G., Sorensen J., Kjeldsen J. L., Yassin H. et al. A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D 3 supplementation in adult patients with migraine. Curr Med Res Opin. 2019; 35 (4): 715–723.
24. Büki B., Jünger H., Zhang Y., Lundberg Y. W. The Price of Immune Responses and the Role of Vitamin D in the Inner Ear. Otol Neurotol. 2019; 40 (6): 701–709. DOI: 10.1097/MAO.0000000000002258.
25. Lippi G., Mattiuzzi C., Meschi T. et al. Homocysteine and migraine. A narrative review. Clinica chimica acta; international journal of clinical chemistry. 2014; 433. DOI: 10.1016/j.cca.2014.02.028.
26. Gavgani S. C., Hoseinian M. M. Comparative study on homocysteine levels in migraine patients and normal peoples. Ann Biol Res 2012; 3: 1804–1807.
27. Cacciapuoti F. Migraine homocysteine-related: old and new mechanisms. Neurology and Clinical Neuroscience. 2017. DOI: 10.1111/ncn3.12128.
28. Isobe C., Terayama Y. A Remarkable Increase in Total Homocysteine Concentrations in the CSF of Migraine Patients With Aura. Headache. 2010; 50: 1561–1569. DOI: 10.1111/j.1526–4610.2010.01713.x.
29. Liampas, Siokas I., Aloizou V., Tsouris A., Metaxia Z., Aslanidou D., Brotis P., Dardiotis A., Efthimios. Pyridoxine, folate and cobalamin for migraine: A Systematic Review. Acta Neurologica Scandinavica. 2020; 142. DOI: 10.1111/ane.13251.
30. R Gatti O. et al. Postural Control in Patients After a Recent Vestibular Neuritis with Hyperhomocysteinemia. Indian Journal of Otolaryngology and Head & Neck Surgery. 2013; 65: 146–150.
31. Goto F., Hayashi K., Kunihiro T., Ogawa K. The possible contribution of angiitis to the onset of benign paroxysmal positional vertigo (BPPV). Int Tinnitus J. 2010; 16 (1): 25–28.
32. Gallai V., Sarchielli P., Firenze C., et al. Endothelin-1 in migraine and tension-type headache. Acta Neurol Scand 1994; 89: 47–55.
33. Hamed S. A., Hamed E. A., Ezz Eldin A. M., et al. Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: Relationship to atherosclerosis. J Stroke Cerebrovasc Dis 2010; 19: 92–103.
34. Kallela M., Faёrkkilaё M., Saijonmaa O., et al. Endothelin in migraine patients. Cephalalgia 1998; 18: 329–332.
35. Nattero G., Mengozzi G., Inconis T., et al. Nitric oxide, endothelin-1, and transcranial Doppler in migraine. Findings in interictal conditions and during migraine attack. Headache 1996; 36: 307–311.
36. Cesar J. M., Garcıґa-Avello A., Vecino A. M., et al. Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand 1995; 91: 412–413.
37. Tietjen G. E., Al Qasmi M. M., Athanas K., et al. Increased von Willebrand factor in migraine. Neurology 2001; 57: 334–336.
38. Guldiken B., Demir M., Guldiken S., et al. Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period. J Clin Neurosci 2009; 16: 672–674.
39. Uzar E., Evliyaoglu O., Toprak G., et al. Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain 2011; 12: 239–243.
Рецензия
Для цитирования:
Беденко А.С. Метаболические факторы в патогенезе мигрени и головокружения. Медицинский алфавит. 2020;(33):18-20. https://doi.org/10.33667/2078-5631-2020-33-18-20
For citation:
Bedenko A.S. Metabolic factors in pathogenesis of migraine and unsteadiness. Medical alphabet. 2020;(33):18-20. (In Russ.) https://doi.org/10.33667/2078-5631-2020-33-18-20